Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Brenda Goodman, MA

    News

    New studies suggest Omicron infections are less severe than Delta ones

    Author:
    Brenda Goodman, MA
    Publish date: December 23, 2021

    “This is helping us quantify how much less severe Omicron is than Delta.”

    • Read More

    News

    Pfizer COVID vaccine for younger children hits snag

    Author:
    Brenda Goodman, MA
    Publish date: December 20, 2021

    Pfizer reported that its 3-microgram dose generated a protective immune response in those aged 6-24 months but didn’t generate adequate immunity...

    • Read More

    News

    CDC panel backs mRNA COVID vaccines over J&J because of clot risk

    Author:
    Brenda Goodman, MA
    Publish date: December 16, 2021

    The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.

    • Read More

    News

    FDA authorizes Pfizer boosters for 16- and 17-year-olds

    Author:
    Brenda Goodman, MA
    Publish date: December 9, 2021

    Early studies suggest that booster doses may be necessary to keep Omicron at bay, at least until new variant-specific vaccines are ready next...

    • Read More

    News

    Vaccine protection drops against Omicron, making boosters crucial

    Author:
    Brenda Goodman, MA
    Publish date: December 9, 2021

    “The strains so far vary by their degree of being neutralized by the antibodies from these vaccines, but they are being neutralized nonetheless...

    • Read More

    News

    Second U.S. COVID-19 case caused by Omicron found

    Author:
    Brenda Goodman, MA
    Publish date: December 2, 2021

    “This news is concerning, but it is not a surprise.”

    • Read More

    News

    Rapid COVID-19 tests will soon be covered by insurance

    Author:
    Brenda Goodman, MA
    Publish date: December 2, 2021

    The measures are part of a suite of new actions President Joe Biden is expected to announce later today, Dec. 2, in the wake of the arrival of the...

    • Read More

    News

    FDA panel backs first pill for COVID-19 by a small margin

    Author:
    Brenda Goodman, MA
    Publish date: November 30, 2021

    If authorized by the agency, molnupiravir would be first antiviral agent available as a pill to treat COVID-19.

    • Read More

    News

    Merck’s COVID-19 pill may be less effective than first hoped

    Author:
    Brenda Goodman, MA
    Publish date: November 30, 2021

    The new results seem to put molnupiravir far below the effectiveness of existing treatments.

    • Read More

    News

    CDC: All adults should be eligible for Pfizer, Moderna boosters

    Author:
    Brenda Goodman, MA
    Publish date: November 19, 2021

    More than 70 million adults are now eligible for booster shots in the United States, but only about 31 million people have received one.

    • Read More

    News

    FDA authorizes COVID boosters for all U.S. adults

    Author:
    Brenda Goodman, MA
    Publish date: November 19, 2021

    The CDC’s Advisory Committee on Immunization Practices will meet on Nov. 19 to review the science supporting a more widespread need for booster...

    • Read More

    News

    Infected, vaccinated, or both: How protected am I from COVID-19?

    Author:
    Brenda Goodman, MA
    Publish date: November 10, 2021

    Memory B cells generated by infections may be immunological Swiss Army Knives, but maybe we really only need a single blade.

    • Read More

    News

    COVID-19 pill 'real game-changer' for preventing COVID death

    Author:
    Brenda Goodman, MA
    Publish date: November 5, 2021

    The medication appears to work so well that Pfizer has stopped enrollment in the trial of the drug, which works by blocking a protease that the...

    • Read More

    News

    FDA authorizes Pfizer’s COVID-19 vaccine for kids

    Author:
    Brenda Goodman, MA
    Publish date: October 29, 2021

    As soon as the CDC’s director signs off on those recommendations, children can get the shots, perhaps as early as Nov. 3.

    • Read More

    News

    FDA panel votes to approve Pfizer’s vaccine for children

    Author:
    Brenda Goodman, MA
    Publish date: October 26, 2021

    If the FDA follows the recommendation, as it typically does, ...the shots could be available within days.

    • Read More

    Pages

    • 1
    • 2
    • 3
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery